Are organ preservation and maintenance of sexual function compatible with optimal management of prostate cancer? Part 2--Advanced cancer.
Pavone-Macaluso
M
M
D000726:Androgen Antagonists / Q000627:therapeutic use; D003131:Combined Modality Therapy; D007172:Erectile Dysfunction / Q000517:prevention & control*; D005485:Flutamide / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D048289:Imidazolidines; D008297:Male; D011471:Prostatic Neoplasms / Q000503:physiopathology / Q000628:therapy*; D013739:Testosterone / Q000097:blood
D000726:Androgen Antagonists; D007093:Imidazoles; D048289:Imidazolidines; D013739:Testosterone; C021277:nilutamide; D005485:Flutamide